Literature DB >> 10201400

A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide.

V Tugarinov1, A Zvi, R Levy, J Anglister.   

Abstract

The refined solution structure of an 18-residue HIV-1IIIB V3 peptide in complex with the Fv fragment of an anti-gp120 antibody reveals an unexpected type VI beta-turn comprising residues RGPG at the center of a beta-hairpin. The central glycine and proline of this turn are linked by a cis peptide bond. The residues of the turn interact extensively with the antibody Fv. 15N[1H] NOE measurements show that the backbone of the peptide, including the central QRGPGR loop, is well ordered in the complex. The solution structure is significantly different from the X-ray structures of HIV-1MN V3 peptides bound to anti-peptide antibodies. These differences could be due to a two-residue (QR) insertion preceding the GPGR sequence in the HIV-1IIIB strain, and the much longer peptide epitope immobilized by the anti-gp120 antibody.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201400     DOI: 10.1038/7567

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  12 in total

1.  Development of small molecules designed to modulate protein-protein interactions.

Authors:  Ye Che; Bernard R Brooks; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2006-04-19       Impact factor: 3.686

2.  Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid state NMR REDOR measurements.

Authors:  J J Balbach; J Yang; D P Weliky; P J Steinbach; V Tugarinov; J Anglister; R Tycko
Journal:  J Biomol NMR       Date:  2000-04       Impact factor: 2.835

3.  An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120.

Authors:  Adi Moseri; Subramanyam Tantry; Yael Sagi; Boris Arshava; Fred Naider; Jacob Anglister
Journal:  Virology       Date:  2010-03-26       Impact factor: 3.616

4.  An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.

Authors:  Meital Abayev; Adi Moseri; Oren Tchaicheeyan; Naama Kessler; Boris Arshava; Fred Naider; Tali Scherf; Jacob Anglister
Journal:  FEBS J       Date:  2015-03-18       Impact factor: 5.542

5.  Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.

Authors:  Brian O'Nuallain; Amy Allen; Stephen J Kennel; Deborah T Weiss; Alan Solomon; Jonathan S Wall
Journal:  Biochemistry       Date:  2007-02-06       Impact factor: 3.162

6.  Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.

Authors:  Amit Mor; Eugenia Segal; Brenda Mester; Boris Arshava; Osnat Rosen; Fa-Xiang Ding; Joseph Russo; Amnon Dafni; Fabian Schvartzman; Tali Scherf; Fred Naider; Jacob Anglister
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

7.  A rapid method to attain isotope labeled small soluble peptides for NMR studies.

Authors:  Bernd W Koenig; Marco Rogowski; John M Louis
Journal:  J Biomol NMR       Date:  2003-07       Impact factor: 2.835

8.  Minute time scale prolyl isomerization governs antibody recognition of an intrinsically disordered immunodominant epitope.

Authors:  Marisol Fassolari; Lucia B Chemes; Mariana Gallo; Clara Smal; Ignacio E Sánchez; Gonzalo de Prat-Gay
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

9.  Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.

Authors:  Miroslaw K Gorny; Constance Williams; Barbara Volsky; Kathy Revesz; Sandra Cohen; Victoria R Polonis; William J Honnen; Samuel C Kayman; Chavdar Krachmarov; Abraham Pinter; Susan Zolla-Pazner
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Force-dependent isomerization kinetics of a highly conserved proline switch modulates the mechanosensing region of filamin.

Authors:  Lorenz Rognoni; Tobias Möst; Gabriel Žoldák; Matthias Rief
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.